Venture • Marketing

Easton Capital Investment Group Invests In IGA Worldwide

On February 7, 2006, venture capital firm Easton Capital Investment Group invested in marketing company IGA Worldwide

Investment Context

This is Easton Capital Investment Group’s 1st transaction in the Marketing sector.
This is Easton Capital Investment Group’s 9th transaction in the United States.
This is Easton Capital Investment Group’s 2nd transaction in New York.

Investment Fate

IGA Worldwide was sold to a strategic buyer in 2014.

Explore All 62 Venture Marketing Deals - Search the Database Free

Investment Summary
Date	February 7, 2006
Target	IGA Worldwide
Sector	Marketing
Investor(s)	Easton Capital Investment Group
Deal Type	Venture

Target Company

IGA Worldwide

New York, New York, United States

IGA Worldwide provides in-game advertising solutions, helping brands to achieve measurable results through its proprietary ad serving network. IGA enables advertisers to target millions of engaged consumers across a broad range of game platforms, titles, and genres. IGA Worldwide is based in New York City.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

Easton Capital Investment Group

New York, New York, United States

Investor Investor

Category	Venture Capital Firm
Founded	2000
PE ASSETS	200M USD
Size	Small
Type	Sector Focused

DESCRIPTION

Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York, New York.

Deal Context for Investor	#
Overall	9 of 25
Sector: Marketing	1 of 1
Type: Venture	7 of 22
State: New York	2 of 4
Country: United States	9 of 25
Year: 2006	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2006-02-01	Acorda Therapeutics Pearl River, New York, United States Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis and related neurological conditions such as spinal cord injury (SCI). Acorda Therapeutics was founded in 1995 and is headquartered in Pearl River, New York.	Sell	-

DATE

TARGET

DEAL TYPE

VALUE

2006-02-01

Acorda Therapeutics

Pearl River, New York, United States

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis and related neurological conditions such as spinal cord injury (SCI). Acorda Therapeutics was founded in 1995 and is headquartered in Pearl River, New York.

Sell

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2006-04-01	Targacept Winston-Salem, North Carolina, United States Targacept is a R&D pharmaceutical company. Targacept is involved with the development and commercialization of drugs based on selective activation of a previously unexploited class of targets - neuronal nicotinic acetylcholine receptors (NNRs). These drugs offer a new way to treat various major CNS and gastrointestinal diseases and disorders including Alzheimer's Disease, depression and ulcerative colitis.	Sell	-

DATE

TARGET

DEAL TYPE

VALUE

2006-04-01

Targacept

Winston-Salem, North Carolina, United States

Targacept is a R&D pharmaceutical company. Targacept is involved with the development and commercialization of drugs based on selective activation of a previously unexploited class of targets - neuronal nicotinic acetylcholine receptors (NNRs). These drugs offer a new way to treat various major CNS and gastrointestinal diseases and disorders including Alzheimer's Disease, depression and ulcerative colitis.